Company Filing History:
Years Active: 2011
Title: Innovations of Alexis Parenty in DNA Binding Agents
Introduction
Alexis Parenty is a prominent inventor based in Glasgow, GB. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential applications in cancer treatment. Her work focuses on phenanthridinium derivatives, which are essential for advancing medical research.
Latest Patents
One of her notable patents is titled "Phenanthridinium derivatives as DNA binding agents." This patent discloses new classes of phenanthridinium derivatives, specifically dihydro-imidazo-phenanthridinium (DIP) compounds. The compounds are synthesized through the reaction of the middle b ring of a phenanthridinium core with primary amines, leading to the formation of DIP compounds. This innovative reaction can also be applied to other classes of starting compounds that include a 6-membered ring aromatic heterocycle with a ring nitrogen and at least one alpha hydrogen atom, which can react with a primary amine. Furthermore, the patent outlines a method for utilizing these DIP compounds in the treatment of ovarian cancer.
Career Highlights
Alexis Parenty is affiliated with the University of Glasgow, where she conducts her research and development activities. Her work has garnered attention for its potential impact on cancer therapies, showcasing her dedication to advancing scientific knowledge and improving patient outcomes.
Collaborations
Some of her notable coworkers include Leroy Cronin and Robert Brown, who contribute to her research endeavors and help foster a collaborative environment in the pursuit of innovative solutions.
Conclusion
Alexis Parenty's contributions to the field of chemistry, particularly through her patent on phenanthridinium derivatives, highlight her role as a leading inventor in the development of new treatments for ovarian cancer. Her work exemplifies the intersection of innovation and medical research, paving the way for future advancements in cancer therapy.